Should biosimilars approvals require clinical trials?

A recent article at TheHill.com notes that there is no mandatory clinical trials for biosimilars. Could this have a direct impact on the ultimate safety and effectiveness of these new generic drugs? Just one impact could be the proper dosage associated in prescribing these drugs. What do you think? Could clinical trials benefit the effectiveness of biosimilars?

Share this article with your social network, just click below to share now!

Share |